Reversal of T-cell Tolerance in Myelodysplastic Syndrome through Lenalidomide Immune Modulation

Lignende værker

• Immune dysregulation in myelodysplastic syndrome
  af: Sugimori, Chiharu, et al.
  Udgivet: (2010)
• Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
  af: McDaniel, Jessica M., et al.
  Udgivet: (2012)
• Telomere length in myelodysplastic syndromes
  af: Rollison, Dana E., et al.
  Udgivet: (2011)
• A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction
  af: Komrokji, Rami S., et al.
  Udgivet: (2014)
• Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
  af: Duong, Vu H., et al.
  Udgivet: (2012)